AGE MORE 60YR

Clinical trials for AGE MORE 60YR explained in plain language.

Never miss a new study

Get alerted when new AGE MORE 60YR trials appear

Sign up with your email to follow new studies for AGE MORE 60YR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Completed 1

New hope for older AML patients: triple drug combo aims to control disease and prevent relapse

Disease control Completed

This study tested a combination of three drugs (low-dose cytarabine or azacitidine, plus venetoclax and quizartinib) in 113 adults aged 60 and older with newly diagnosed acute myeloid leukemia (AML) who were not eligible for standard chemotherapy. The goal was to quickly control …

Matched conditions: AGE MORE 60YR

Phase: PHASE1, PHASE2 • Sponsor: PETHEMA Foundation • Aim: Disease control

Last updated Jun 27, 2026 12:32 UTC

AGE MORE 60YR

Get alerted when new AGE MORE 60YR trials appear

New hope for older AML patients: triple drug combo aims to control disease and prevent relapse